...
首页> 外文期刊>Current cancer therapy reviews >Phenothiazines and Related Drugs as Multi Drug Resistance Reversal Agents in Cancer Chemotherapy Mediated by p-glycoprotein
【24h】

Phenothiazines and Related Drugs as Multi Drug Resistance Reversal Agents in Cancer Chemotherapy Mediated by p-glycoprotein

机译:吩噻嗪和相关药物作为P-糖蛋白介导的癌症化疗中多种耐药逆转剂

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Multi Drug Resistance (MDR) is one of the main hindrances in the successful treatment of cancer by natural agents. Most of the natural anticancer drugs are effluxed by the P-glycoprotein resulting in the failure of cancer chemotherapy. Phenothiazines and related drugs are one of the first drugs investigated for the reversal of MDR. Exhaustive studies have been done to develop potent phenothiazines analogues for MDR reversal activity. Materials and Methods: Quantitative Structural Activity Relationship (QSAR) and Structural Activity Relationship (SAR) studies of phenothiazines have provided some fruitful results in order to develop potent anti-MDR phenothiazine drugs but no success has been achieved yet. The main mechanism through which phenothiazines act on the P-glycoprotein includes the same binding site of vinblastine drug and it inhibits the efflux of such drugs. To develop a potent anti-MDR agent, it is indispensable to study the mechanism of efflux of anticancer drugs by P-gp, SAR and QSAR studies of phenothiazines as anti-MDR agents and mechanism of phenothiazines as anti-MDR agents simultaneously.
机译:背景:多重耐药性(MDR)是天然药剂成功治疗癌症的主要障碍之一。大多数天然抗癌药物被P-糖蛋白从癌症化疗失败导致癌症化疗失败。吩噻嗪和相关药物是第一种针对MDR逆转的药物之一。已经进行了详尽的研究,以开发有效的吩噻嗪类类似物用于MDR逆转活动。材料和方法:吩噻嗪的定量结构活动关系(QSAR)和结构活动关系(SAR)研究提供了一些富有成效的结果,以便开发有效的抗MDR吩噻嗪药,但尚未取得成功。吩噻嗪对P-糖蛋白作用的主要机制包括导致药物的相同结合位点,抑制这种药物的渗透。为了开发有效的抗MDR代理,研究P-GP,SAR和吩噻嗪作为抗MDR代理的P-GP,SAR和QSAR研究作为抗MDR代理的抗MDR代理的机制是必不可少的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号